Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - granisetronhydrochlorid - filmovertrukne tabletter - 1 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

s.a.l.f. s.p.a. - ketorolactrometamol - injektionsvæske, opløsning - 30 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - buprenorphinhydrochlorid - resoribletter, sublinguale - 8 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

laboratoires smb s.a. - buprenorphinhydrochlorid, naloxonhydrochloriddihydrat - resoribletter, sublinguale - 2+0,5 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

accord healthcare b.v. - atropinsulfat - injektionsvæske, opløsning i fyldt injektionssprøjte - 0,1 mg/ml

Den Europæiske Union - dansk - EMA (European Medicines Agency)

accord healthcare s.l.u. - plerixafor - multiple myeloma; hematopoietic stem cell transplantation - immunostimulants, - adult patientsplerixafor accord is indicated in combination with granulocyte-colony stimulating factor (g-csf) to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in adult patients with lymphoma or multiple myeloma whose cells mobilise poorly (see section 4. paediatric patients (1 to less than 18 years)plerixafor accord is indicated in combination with g-csf to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in children with lymphoma or solid malignant tumours, either:- pre-emptively, when circulating stem cell count on the predicted day of collection after adequate mobilization with g-csf (with or without chemotherapy) is expected to be insufficient with regards to desired hematopoietic stem cells yield, or- who previously failed to collect sufficient haematopoietic stem cells (see section 4.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

seacross pharma (europe) limited - plerixafor - injektionsvæske, opløsning - 20 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

teva gmbh - plerixafor - injektionsvæske, opløsning - 20 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

vivanta generics s.r.o. - plerixafor - injektionsvæske, opløsning - 20 mg/ml

Den Europæiske Union - dansk - EMA (European Medicines Agency)

gsk vaccines s.r.l. - ydre membran vesikler fra neisseria meningitidis gruppe b (stamme nz 98/254), rekombinant neisseria meningitidis gruppe b fhbp fusion protein, rekombinant neisseria meningitidis gruppe b nada protein, rekombinant neisseria meningitidis gruppe b nhba fusion protein - meningitis, meningokok - meningokokvacciner - aktiv immunisering mod invasiv sygdom forårsaget af neisseria meningitidis serogruppe b-stammer.